Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of the International AIDS Society
Published in: Journal of the International AIDS Society 3/2010

Open Access 01-12-2010 | Oral presentation

The role of the ubiquitin-proteasome pathway in rhTRIM5α restriction of HIV-1

Authors: CM Danielson, TJ Hope

Published in: Journal of the International AIDS Society | Special Issue 3/2010

Login to get access

Excerpt

rhTRIM5α is a restriction factor that blocks HIV-1 infection by interacting with the capsid core early after entry. Although rhTRIM5α blocks accumulation of reverse transcription products, proteasome inhibitors rescue reverse transcription while maintaining a block to infection, supporting the involvement of the proteasome in the mechanism of restriction. …
Metadata
Title
The role of the ubiquitin-proteasome pathway in rhTRIM5α restriction of HIV-1
Authors
CM Danielson
TJ Hope
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-13-S3-O9

Other articles of this Special Issue 3/2010

Journal of the International AIDS Society 3/2010 Go to the issue

Oral presentation

Tetherin restricts direct cell-cell viral transfer and transmission of HIV-1

Oral presentation

CD4+ T cell reconstitution, T cell activation, and memory T cell subset composition in blood and gut of HIV-negative and ART-suppressed HIV-positive patients: implications for HIV persistence in the gut

Meeting report

Workshop report: “Towards a Cure: HIV Reservoirs and Strategies to Control Them”

Oral presentation

Purging the HIV-1 reservoir through the disruption of the PD-1 pathway

Oral presentation

Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia

Oral presentation

Novel pathways of transcriptional and post-transcriptional regulation of post-integrative HIV-1 latency
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits